499 Myeloid diversity in hormone receptor positive breast cancer reveals myeloid and lymphoid signaling pathways that correlate with T cell inhibition

499 Myeloid diversity in hormone receptor positive breast cancer reveals myeloid and lymphoid signaling pathways that correlate with T cell inhibition

Bibliographic Details
Main Authors:	Jennifer L Guerriero, Madeline G Townsend, Daniel E Michaud, Kenichi Shimada, Chenyi Gu, Lukas Kania
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies
by: Ricardo D. Parrondo, et al.
Published: (2023-10-01)

Myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA presenting as myeloid sarcoma
by: Mohammad Barouqa, et al.
Published: (2022-08-01)

P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL-WORLD SETTING
by: Enrico Attardi, et al.
Published: (2023-08-01)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
by: Iosif Papafragkos, et al.
Published: (2021-08-01)

Unraveling the Role of Innate Lymphoid Cells in Acute Myeloid Leukemia
by: Matthew R. Lordo, et al.
Published: (2021-01-01)

Regulation of myeloid and lymphoid cell development by O-glycans on Notch
by: Pamela Stanley, et al.
Published: (2022-11-01)

B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
by: Binoy Yohannan, et al.
Published: (2022-10-01)

Long Noncoding RNA in Myeloid and Lymphoid Cell Differentiation, Polarization and Function
by: Imran Ahmad, et al.
Published: (2020-01-01)

Construction and analysis of the protein interaction network between myeloid and lymphoid leukemia types
by: Hamad, Oras Naji
Published: (2023)

Construction and analysis of the protein interaction network between myeloid and lymphoid leukemia types /
by: Oras Naji Hamad, 1983-, author 639762, et al.
Published: (2022)

Construction and analysis of the protein interaction network between myeloid and lymphoid leukemia types /
by: Oras Naji Hamad, 1983-, author 639762
Published: (2020)

Construction and analysis of the protein interaction network between myeloid and lymphoid leukemia types
by: Hamad, Oras Naji
Published: (2022)

Revealing the mechanism of lymphoid and myeloid cell differentiation and transdifferentiation through landscape quantification
by: Chenyong Zhang, et al.
Published: (2021-02-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

FAT1 Gene Expression in Iranian Acute Lymphoid and Myeloid Leukemia Patients
by: Mohammadreza Ostadali Dehaghi, et al.
Published: (2023-04-01)

Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells
by: Calogero eVetro, et al.
Published: (2015-05-01)

Incidental detection of myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement on fluorodeoxyglucose positron emission tomography
by: Hiroki Kobayashi, et al.
Published: (2023-11-01)

Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells
by: Tekpli, X, et al.
Published: (2016)

PB2180: TREATMENT CHALLENGES OF COEXISTING MYELOID AND LYMPHOID NEOPLASM- A CASE REPORT
by: Mihailo Smiljanic, et al.
Published: (2023-08-01)

Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders
by: Burak Uz, et al.
Published: (2013-12-01)

CUMULATIVE INCIDENCE OF LYMPHOID AND MYELOID LEUKEMIAS IN DIFFERENT REGIONS OF THE CHERKASSY REGION IN 2001 AND 2014
by: V.V. Paramonov, et al.
Published: (2021-06-01)

De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion
by: Maha Hameed, et al.
Published: (2022-12-01)

Inhibition of c-Rel expression in myeloid and lymphoid cells with distearoyl -phosphatidylserine (DSPS) liposomal nanoparticles encapsulating therapeutic siRNA.
by: Christian Bressy, et al.
Published: (2022-01-01)

Inhibition of c-Rel expression in myeloid and lymphoid cells with distearoyl -phosphatidylserine (DSPS) liposomal nanoparticles encapsulating therapeutic siRNA
by: Christian Bressy, et al.
Published: (2022-01-01)

Corrigendum to “Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia” [Bioact. Mater. 21 (March 2023) 499–510]
by: Yifeng Xia, et al.
Published: (2024-01-01)

Dietary intakes and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Saberi Hosnijeh, F, et al.
Published: (2014)

An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.
by: Berger, M, et al.
Published: (2010)

Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion.
by: Nygren, J, et al.
Published: (2008)

Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC).
by: Saberi Hosnijeh, F, et al.
Published: (2013)

Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC)
by: Saberi Hosnijeh, F, et al.
Published: (2012)

Dietary Intakes and Risk of Lymphoid and Myeloid Leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC)
by: Hosnijeh, F, et al.
Published: (2014)

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
by: Verena Petzer, et al.
Published: (2022-03-01)

Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage—Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities
by: Lukasz Komorowski, et al.
Published: (2020-08-01)

570 Successful immune-checkpoint therapy promotes spatial reorganization of the lymphoid and myeloid cellular populations
by: Robert Schreiber, et al.
Published: (2023-11-01)

Correction: Refinement of 1p36 Alterations Not Involving PRDM16 in Myeloid and Lymphoid Malignancies
Published: (2011-01-01)

1485 Characterization of the hormone receptor-positive breast tumor microenvironment using single cell transcriptomics and multi-plex immunofluorescence
by: Elizabeth A Mittendorf, et al.
Published: (2023-11-01)

P499: THE PHASE 1B OMNIVERSE TRIAL OF ORAL AZACITIDINE IN COMBINATION WITH VENETOCLAX FOR TREATMENT OF RELAPSED/REFRACTORY OR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (TRIAL IN PROGRESS)
by: A. H. Wei, et al.
Published: (2022-06-01)

Role of myeloid-derived suppressor cells in hormone-dependent cancers
by: Siddhartha Mukherjee, et al.
Published: (2021-03-01)

The Bone’s Role in Myeloid Neoplasia
by: Lukas Kazianka, et al.
Published: (2020-07-01)

Complement receptors in myeloid cell adhesion and phagocytosis
by: Dustin, M
Published: (2016)